ArticlePharmaceutics2022

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.

Sahar Roshanbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.